The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

SureCN7060144     9-[(4-amino-3-methyl- phenyl)methyl]-4-(2,2...

Synonyms: Exp 655, PD-123177, PDSP1_000582, PDSP1_000648, PDSP1_000649, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

High impact information on Exp 655

  • Oral treatment with PD 123177 (50 mg/liter drinking water) attenuated the glomerular M/M influx without normalizing the slightly elevated systolic blood pressure caused by ANG II infusion, suggesting that the effects on blood pressure and RANTES induction can be separated [1].
  • However, after pretreatment of quiescent endothelial cells (< passage 4) with the AT2-receptor antagonist, PD 123177, ANG II induced proliferation [2].
  • The AT1-receptor antagonist DUP 753 significantly reduced E-selectin-dependent adhesion, whereas the AT2-receptor antagonist PD 123177 had no inhibitory effect [3].
  • About 85% of the binding sites of the glomerulosa zone and 30% of those of the inner zones were of the AT1 subtype, with relative affinities for the nonpeptide antagonists Dup 753 and PD 123177 and the peptide antagonist CGP 42112A in the order of Dup 753 much greater than CGP 42112A greater than PD 123177 [4].
  • In these areas, binding was not affected by the selective AT2 competitors PD 123177 or CGP 42112 A, indicating the presence of AT1 and the absence of AT2 receptors [5].

Biological context of Exp 655


Anatomical context of Exp 655


Associations of Exp 655 with other chemical compounds

  • However, binding of 125I-labeled [Sar1,Ile8]AII in the latter regions was inhibited by the AT2 receptor antagonists PD 123177 and CGP 42112A [12].
  • Both an initial (10 s) and secondary (10 min) phase of DAG production in response to 100 nM Ang II were inhibited by 1 microM losartan (DuP 753), an AT1 antagonist, while 1 microM PD 123177, an AT2 antagonist, was ineffective [13].
  • Specific binding to angiotensin II receptors in heart grafts was displaced by addition of the AT1 receptor antagonist losartan, but not by addition of the AT2 receptor competitor PD 123177 [14].
  • RG 13647 (1(-1,4-benzodioxan-2-methyl)-5-diphenylacetyl-4,5,6,7-tetra hydro-1H-imidazo- [4,5,c]-pyridine-6-carboxylic acid) represents a potent and AT2-selective analog of PD 123177 and showed weak activity in competing for [125I]angiotensin II binding with an IC50 value of 100 microM [15].
  • In the present study we attempted to mimic the actions of PD-123319 by giving a supramaximal dose of EXP-3174 (10 micrograms), and we also assessed the effects of PD-123177 (80 micrograms), an AT2-receptor antagonist that differs from PD-123319 only by a dimethyl group [16].

Gene context of Exp 655

  • Conversely, the AT2 receptor antagonist PD 123177 (1 mumol/L) was ineffective [17].
  • RESULTS: All binding in the presence of DUP 753 and PD 123177 confirmed that nuclear All receptors can be classified as AT1 receptors and that as much as 10% of the specific binding is attributable to nuclear chromatin [18].
  • The sites having high affinity for DuP 753 are designated as site 1 (AT1 receptors) and those having a high affinity for PD 123177 as site 2 (AT2 receptors) [19].
  • In contrast, both CGP 42112A (10 and 100 microM, n = 12) and PD 123177 (100 microM, n = 7) failed to block excitation by Ang II in all neurons tested [20].
  • Pretreatment of the PVN with losartan or the AT2 receptor antagonist, PD 123177 (4 nmol/200 nl), inhibited the 100 pmol ANG (1-7)-induced AVP release [21].


  1. Angiotensin II stimulates expression of the chemokine RANTES in rat glomerular endothelial cells. Role of the angiotensin type 2 receptor. Wolf, G., Ziyadeh, F.N., Thaiss, F., Tomaszewski, J., Caron, R.J., Wenzel, U., Zahner, G., Helmchen, U., Stahl, R.A. J. Clin. Invest. (1997) [Pubmed]
  2. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. Stoll, M., Steckelings, U.M., Paul, M., Bottari, S.P., Metzger, R., Unger, T. J. Clin. Invest. (1995) [Pubmed]
  3. Angiotensin II-induced leukocyte adhesion on human coronary endothelial cells is mediated by E-selectin. Gräfe, M., Auch-Schwelk, W., Zakrzewicz, A., Regitz-Zagrosek, V., Bartsch, P., Graf, K., Loebe, M., Gaehtgens, P., Fleck, E. Circ. Res. (1997) [Pubmed]
  4. Angiotensin II receptor subtypes and biological responses in the adrenal cortex and medulla. Balla, T., Baukal, A.J., Eng, S., Catt, K.J. Mol. Pharmacol. (1991) [Pubmed]
  5. Angiotensin-II receptor subtypes in median eminence and basal forebrain areas involved in regulation of pituitary function. Tsutsumi, K., Saavedra, J.M. Endocrinology (1991) [Pubmed]
  6. Angiotensin II stimulates the release of phospholipid-derived second messengers through multiple receptor subtypes in heart cells. Lokuta, A.J., Cooper, C., Gaa, S.T., Wang, H.E., Rogers, T.B. J. Biol. Chem. (1994) [Pubmed]
  7. Placental aminopeptidase A as a possible barrier of angiotensin II between mother and fetus. Hariyama, Y., Itakura, A., Okamura, M., Ito, M., Murata, Y., Nagasaka, T., Nakazato, H., Mizutani, S. Placenta (2000) [Pubmed]
  8. Angiotensin-II receptor subtypes in fetal tissue of the rat: autoradiography, guanine nucleotide sensitivity, and association with phosphoinositide hydrolysis. Tsutsumi, K., Strömberg, C., Viswanathan, M., Saavedra, J.M. Endocrinology (1991) [Pubmed]
  9. Pharmacological characterization of angiotensin II binding sites in the canine pancreas. Chappell, M.C., Diz, D.I., Jacobsen, D.W. Peptides (1992) [Pubmed]
  10. Localization of angiotensin AT1 receptors in the rat heart conduction system. Saavedra, J.M., Viswanathan, M., Shigematsu, K. Eur. J. Pharmacol. (1993) [Pubmed]
  11. Characterization and coupling of angiotensin-II receptor subtypes in cultured bovine adrenal fasciculata cells. Ouali, R., Poulette, S., Penhoat, A., Saez, J.M. J. Steroid Biochem. Mol. Biol. (1992) [Pubmed]
  12. Differential distribution of AT1 and AT2 angiotensin II receptor subtypes in the rat brain during development. Millan, M.A., Jacobowitz, D.M., Aguilera, G., Catt, K.J. Proc. Natl. Acad. Sci. U.S.A. (1991) [Pubmed]
  13. Vascular smooth-muscle cells contain AT1 angiotensin receptors coupled to phospholipase D activation. Freeman, E.J., Tallant, E.A. Biochem. J. (1994) [Pubmed]
  14. Sympathetic innervation modulates the expression of angiotensin II receptors in embryonic rat heart grafted in oculo. Hunt, R.A., Ciuffo, G.M., Saavedra, J.M., Tucker, D.C. J. Mol. Cell. Cardiol. (1995) [Pubmed]
  15. The angiotensin hexapeptide 3-8 fragment potently inhibits [125I]angiotensin II binding to non-AT1 or -AT2 recognition sites in bovine adrenal cortex. Jarvis, M.F., Gessner, G.W., Ly, C.Q. Eur. J. Pharmacol. (1992) [Pubmed]
  16. Differential blockade of central effects of angiotensin II by AT2-receptor antagonists. Widdop, R.E., Gardiner, S.M., Kemp, P.A., Bennett, T. Am. J. Physiol. (1993) [Pubmed]
  17. Angiotensins differentially activate phospholipase D in vascular smooth muscle cells from spontaneously hypertensive and Wistar-Kyoto rats. Freeman, E.J., Ferrario, C.M., Tallant, E.A. Am. J. Hypertens. (1995) [Pubmed]
  18. Hepatic angiotensin II nuclear receptors and transcription of growth-related factors. Eggena, P., Zhu, J.H., Sereevinyayut, S., Giordani, M., Clegg, K., Andersen, P.C., Hyun, P., Barrett, J.D. J. Hypertens. (1996) [Pubmed]
  19. Angiotensin II receptor subtypes. Timmermans, P.B., Chiu, A.T., Herblin, W.F., Wong, P.C., Smith, R.D. Am. J. Hypertens. (1992) [Pubmed]
  20. Receptor subtype that mediates the neuronal effects of angiotensin II in the rat dorsal medulla. Barnes, K.L., McQueeney, A.J., Ferrario, C.M. Brain Res. Bull. (1993) [Pubmed]
  21. Sensitivity of hypothalamic paraventricular nucleus to C- and N-terminal angiotensin fragments: vasopressin release and drinking. Qadri, F., Wolf, A., Waldmann, T., Rascher, W., Unger, T. J. Neuroendocrinol. (1998) [Pubmed]
WikiGenes - Universities